GlassScriptPhysician profile
Edet O Bassey
NPI 1336123181
$1,215.53
in general payments reported to CMS, 2019-2025
19 companies · $75.23 in 2025
The $75.23 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.05 · 2020: $96.43 · 2021: $101 · 2022: $454 · 2023: $163 · 2024: $235 · 2025: $75.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $397.78 | 2022-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $191.81 | 2022-2023 | Verquvo, Steglatro, Belsomra |
| Novo Nordisk INC | $115.37 | 2019-2021 | |
| Lilly USA, LLC | $69.19 | 2021-2024 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $63.66 | 2020-2022 | |
| Abbott Laboratories | $58.89 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $45.45 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $33.97 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $31.88 | 2022-2024 | Gvoke Hypopen |
| Amgen INC. | $29.89 | 2024-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $28.99 | 2021-2024 | |
| Global Blood Therapeutics, INC. | $23.96 | 2022 | |
| Medtronic Minimed, INC. | $22.78 | 2019 | |
| Sumitomo Pharma America, INC. | $22.14 | 2025 | Gemtesa |
| Laborie Medical Technologies Corp. | $19.11 | 2024 | Endosheath Technology |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.03 | 2025 | |
| Exact Sciences Corporation | $17.02 | 2024 | Cologuard Collection Kit |
| Eisai INC. | $14.07 | 2021 | |
| Esperion Therapeutics, INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edet Bassey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.